Evidence map›Paper›PMID 39675352›Full record

ArticleAutophagy2025

AMPK protects proximal tubular epithelial cells from lysosomal dysfunction and dedifferentiation induced by lipotoxicity.

Louise Pierre, Florian Juszczak, Valentine Delmotte, Morgane Decarnoncle, Benjamin Ledoux, Laurent Bultot, Luc Bertrand, Marielle Boonen, Patricia Renard, Thierry Arnould and 1 more

Abstract read
In one paragraph

Article in Autophagy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. IGFBP7: A potential target for tubular lipogenesis in CKD.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Louise PierreLaboratory of Biochemistry and Cell Biology, Namur Research Institute for Life Sciences (NARILIS), University of Namur, Namur, Belgium.ORCID 0009-0007-3332-1432
Florian JuszczakLaboratory of Metabolic and Molecular Biochemistry, Faculty of Medicine and Pharmacy, Research Institute for Health Sciences and Technology, University of Mons, Mons, Belgium.ORCID 0000-0001-8526-0204
Valentine DelmotteLaboratory of Biochemistry and Cell Biology, Namur Research Institute for Life Sciences (NARILIS), University of Namur, Namur, Belgium.
Morgane DecarnoncleLaboratory of Metabolic and Molecular Biochemistry, Faculty of Medicine and Pharmacy, Research Institute for Health Sciences and Technology, University of Mons, Mons, Belgium.ORCID 0000-0003-3259-4109
Benjamin LedouxLaboratory of Biochemistry and Cell Biology, Namur Research Institute for Life Sciences (NARILIS), University of Namur, Namur, Belgium.ORCID 0009-0004-0336-6478
Laurent BultotPole of Cardiovascular Research, Experimental and Clinical Research Institute (CARD), UCLouvain, Brussels, Belgium.ORCID 0000-0002-5088-0101
Luc BertrandPole of Cardiovascular Research, Experimental and Clinical Research Institute (CARD), UCLouvain, Brussels, Belgium.ORCID 0000-0003-0655-7099
Marielle BoonenURPhyM, Intracellular Trafficking Biology, NARILIS, University of Namur, Namur, Belgium.ORCID 0000-0002-1884-7846
Patricia RenardLaboratory of Biochemistry and Cell Biology, Namur Research Institute for Life Sciences (NARILIS), University of Namur, Namur, Belgium.ORCID 0000-0003-4144-3353
Thierry ArnouldLaboratory of Biochemistry and Cell Biology, Namur Research Institute for Life Sciences (NARILIS), University of Namur, Namur, Belgium.ORCID 0000-0003-2101-2660
Anne-Emilie DeclèvesLaboratory of Metabolic and Molecular Biochemistry, Faculty of Medicine and Pharmacy, Research Institute for Health Sciences and Technology, University of Mons, Mons, Belgium.ORCID 0000-0002-0838-2432

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal proximal tubules are a primary site of injury in metabolic diseases. In obese patients and animal models, proximal tubular epithelial cells (PTECs) display dysregulated lipid metabolism, organelle dysfunctions, and oxidative stress that contribute to interstitial inflammation, fibrosis and ultimately end-stage renal failure. Our research group previously pointed out AMP-activated protein kinase (AMPK) decline as a driver of obesity-induced renal disease. Because PTECs display high macroautophagic/autophagic activity and rely heavily on their endo-lysosomal system, we investigated the effect of lipid stress on autophagic flux and lysosomes in these cells. Using a model of highly differentiated primary PTECs challenged with palmitate, our data placed lysosomes at the cornerstone of the lipotoxic phenotype. As soon as 6 h after palmitate exposure, cells displayed impaired lysosomal acidification subsequently leading to autophagosome accumulation and activation of lysosomal biogenesis. We also showed the inability of lysosomal quality control to restore acidic pH which finally drove PTECs dedifferentiation. When palmitate-induced AMPK activity decline was prevented by AMPK activators, lysosomal acidification and the differentiation profile of PTECs were preserved. Our work provided key insights on the importance of lysosomes in PTECs homeostasis and lipotoxicity and demonstrated the potential of AMPK in protecting the organelle from lipid stress.

Indexed as

AMP-Activated Protein KinasesCell DedifferentiationEpithelial CellsKidney Tubules, ProximalLysosomesAnimalsAutophagosomesAutophagyHumansLipid MetabolismMicePalmitatesAMP-Activated Protein KinasesPalmitatesAMPKAutophagychronic kidney diseaselipid accumulationobesityproximal tubules

Identifiers

PMID39675352
PMCPMC11925112

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.